Showing papers by "Donald V. Lightner published in 2007"

Biosecurity in Shrimp Farming: Pathogen Exclusion through Use of SPF Stock and Routine Surveillance

Abstract: Biosecurity, as it is being applied to shrimp aquaculture, may be defined as the practice of exclusion of specific pathogens from cultured aquatic stocks in brood stock facilities, hatcheries, and farms, or from entire regions or countries for the purpose of disease prevention. To make a biosecurity program a functional concept in shrimp aquaculture, the relevant risks should be identified and the appropriate biosecurity measures put into practice to mitigate those risks. Examples of biosecurity measures put into place for this purpose may include such basics as site selection when the intent is to locate a new shrimp culture facility in an area where certain diseases are not enzootic. Standard facilitylfarm operating procedures can be adapted to minimize the risks of disease introduction and spread within a facility through such concepts as pretreatment of all source water, and reduced or “zero” water exchange. Stocking shrimp culture facilities with domesticated shrimp stocks that are free of specific diseases (“Specific Pathogen Free” or SPF) and or with stocks resistant to specific disease agents (SPR) is perhaps the most important single component of a biosecurity program. The example set by the development of domesticated SPF stocks of Litopenaeus vannamei has helped to make biosecure shrimp culture feasible. The development of these and other SPF stocks, and the diagnostic methods to develop and monitor them for specific diseases and disease causing agents, have been milestones in the development of the international shrimp farming industry in recent years, and it has contributed to the species rivaliig Penaeus monodon as the dominant farmed shrimp species. The regular monitoring (surveillance) of shrimp stocks in biosecure culture facilities is a necessary component of a biosecurity plan, as is having in place a contingency plan for disease containment and eradication should a breach occur in the physical and managerial components of a biosecure facility and a targeted disease occur.

PCR assay for discriminating between infectious hypodermal and hematopoietic necrosis virus (IHHNV) and virus-related sequences in the genome of Penaeus monodon.

Abstract: We developed a PCR assay that can detect infectious hypodermal and hematopoietic necrosis virus (IHHNV) but that does not react with IHHNV-related sequences in the genome of Penaeus monodon from Africa and Australia. IHHNV is a single-stranded DNA virus that has caused severe mortality and stunted growth in penaeid shrimp. Recently, IHHNV-related sequences were found in the genome of some stocks of P. monodon from Africa and Australia. These virus-related sequences have a high degree of similarity (86 and 92% identities in nucleotide sequence) to the viral genome, which has often generated false-positive reactions during PCR screening of these stocks. For this assay, a pair of IHHNV primers (IHHNV309F/R) was selected. The sequences of these primers match (100% of nucleotides) the target sequence in IHHNV, but mismatch 9 or 12 nucleotides of the genomic IHHNV-related sequences. This PCR assay was tested with various IHHNV isolates and with a number of samples of shrimp DNA that contained IHHNV-related sequences. This assay can reliably distinguish IHHNV DNA from shrimp DNA: it only detects IHHNV. Also, this pair of primers was included in a duplex PCR to detect IHHNV and simultaneously determine the presence of an IHHNV-related sequence. Using these primers, the PCR assay has a sensitivity equivalent to a PCR assay commonly used for detecting IHHNV in Litopenaeus vannamei, and can be used for routine detection.

Development of in situ hybridization and RT-PCR assay for the detection of a nodavirus (PvNV) that causes muscle necrosis in Penaeus vannamei.

Abstract: A nodavirus (tentatively named PvNV, Penaeus vannamei nodavirus) that causes mus- cle necrosis in P. vannamei was found in Belize in 2004. From 2004 to 2006, shrimp samples collected from Belize exhibited clinical signs, white, opaque lesions in the tails and histopathology similar to those of shrimps infected by infectious myonecrosis virus (IMNV). Histological examination revealed multifocal necrosis and hemocytic fibrosis in the skeletal muscle. In addition, basophilic, cytoplasmic inclusions were found in striated muscle, lymphoid organ and connective tissues. However, IMNV was not detected in these shrimps by either RT-PCR or in situ hybridization, suggesting that these lesions may be caused by another RNA virus. Thus, a cDNA library was constructed from total RNA extracted from hemolymph collected from infected shrimp. One clone (designated PvNV-4) with a 928 bp insert was sequenced and found to be similar (69% similarity when comparing the translated amino acid sequences) to the capsid protein gene of MrNV (Macrobrachium rosenbergii nodavirus). The insert of PvNV-4 was labeled with digoxigenin-11-deoxyuridine triphosphate (dUTP) and hybridized to tissue sections of P. vannamei with muscle necrosis collected in Belize and from labora- tory bioassays. The samples were positive for PvNV infection. Positively reacting tissues included skeletal muscle, connective tissues, the lymphoid organ, and hemocytes in the heart and gills. In addition, we experimentally infected both P. vannamei and P. monodon with PvNV prepared from Belize samples. A nested RT-PCR assay developed from the PvNV-4 cloned sequence showed that both species are susceptible to PvNV infection.

A novel bacterial disease of the European shore crab, Carcinus maenas molecular pathology and epidemiology.

Abstract: Several rickettsia-like diseases have been reported in arthropods (insects and crustaceans), some of which result in significant losses of economically important species such as shrimp and crabs. This study reports on the molecular pathology of a recently emerged disease of the European shore crab, Carcinus maenas, termed milky disease - named as a result of the unusual milky appearance of the haemolymph (blood). This disease was more prevalent (>26 %) during summer months when the water temperature in a pilot crab farm was approximately 19 degrees C. The putative causative agent of the disease was a Gram-negative bacterium that could not be cultured on a range of agar-based growth media. Diseased crabs showed significant reductions in free blood cell numbers and total serum protein. Such animals also displayed raised levels of glucose and ammonium in blood. Ultrastructural and in situ hybridization studies revealed that the causative agent associated with milky disease multiplied in the fixed phagocytes of the hepatopancreas (digestive gland), ultimately to be released into the haemolymph, where the circulating blood cells showed little response to the presence of these agents. Attempts to induce the infection by short-term temperature stress failed, as did transmission experiments where healthy crabs were fed infected tissues from milky disease affected individuals. Sequence analysis of the 16S rRNA gene from the milky disease bacteria indicated that they are a previously undescribed species of alpha-proteobacteria with little phylogenetic similarity to members of the order Rickettsiales.

Characterization of a rediscovered haplosporidian parasite from cultured Penaeus vannamei.

Abstract: Mortalities of Penaeus vannamei, cultured in ponds in Belize, Central America, began during the last part of the grow-out cycle during the cold weather months from September 2004 through February 2005. Tissue squashes of infected hepatopancreata and histological examination of infected shrimp revealed that the mortalities might have been caused by an endoparasite. To confirm the diagnosis, DNA was extracted from ethanol preserved hepatopancreata and the small-subunit rRNA gene was sequenced. The 1838 bp sequence was novel and phylogenetic analysis placed the P. vannamei parasite within the phylum Haplosporidia as a sister taxon to a clade that includes Bonamia and Minchinia species. In situ hybridization was performed using anti-sense DNA probes that were designed to hybridize specifically with the parasite's nucleic acid. This organism presents similar characteristics to those of a haplosporidian that infected cultured P. vannamei imported from Nicaragua into Cuba, as described by Dykova et al. (1988; Fish Dis 11:15-22).

Opportunities for training in shrimp diseases.

Abstract: Opportunities for formal training in shrimp diseases were not available 30 years ago. This was because the shrimp farming industry was in its infancy with few significant disease issues and even fewer shrimp disease specialists investigating the causes of production losses. In 2006, more than two million metric tons of the marine penaeid shrimp were farmed, accounting for more than half of the world's supply. With most of the world's shrimp fisheries at maximum sustainable yields, the ratio of farmed to fished shrimp appears likely to continue to increase. The remarkable growth of sustainable shrimp farming was made possible through the development of methods to diagnose and manage disease in the world's shrimp farms. This occurred as the result of the development of training opportunities in shrimp disease diagnosis and control methods and the application of that knowledge, by an ever increasing number of shrimp diseases specialists, to disease management at shrimp farms. The first type of formal training to become generally available to the industry was in the form of special short courses and workshops. The first of these, which was open to international participants, was given at the University of Arizona in 1989. Since that first course several dozen more special short courses and workshops on shrimp diseases have been given by the University of Arizona. Dozens more special courses and workshops on shrimp diseases have been given by other groups, including other universities, industry cooperatives, governments and international aid agencies, in a wide range of countries (and languages) where shrimp farming constitutes an important industry. In parallel, graduate study programs leading to post graduate degrees, with shrimp disease as the research topic, have developed while formal courses in shrimp diseases have not become widely available in veterinary or fisheries college curricula in the USA and Europe, such courses are appearing in university programs located in some of the shrimp farming countries of SE Asia. The trend towards more formal training programs in shrimp diseases and disease management is likely to continue as the industry continues to mature and become increasingly sustainable.

Taura syndrome virus in specific pathogen-free Penaeus vannamei originating from Hawaii and in P. vannamei stocks farmed in France?

Abstract: It is the opinion of the authors of the Comment on Do et al. (2006), that those authors incorrectly interpreted their test results, which are more likely the result of mislabeling of samples or within-laboratory contamination, and that the TSV isolates found in Penaeus vannamei in Korea in 2004 and 2005 did not originate from Hawaii as claimed by the authors, but from a country (or countries) in southeast Asia. Finally, we believe that the authors did not follow proper international guidelines, extend a professional courtesy to the supplier of the disputed shrimp sample, nor take a critical approach in interpreting their own data. It is unfortunate that the authors did not follow through with additional testing, or seek a second opinion from an independent laboratory, before implicating shrimp imported from Hawaii as the source of TSV in Korea.

Taura syndrome virus in specific pathogen-free Penaeus vannamei originating from Hawaii and in P. vannamei stocks farmed in France? Commentary and Authors' reply

Abstract: It is the opinion of the authors of the Comment on Do et al. (2006), that those authors incorrectly interpreted their test results, which are more likely the result of mislabeling of samples or within-laboratory contamination, and that the TSV isolates found in Penaeus vannamei in Korea in 2004 and 2005 did not originate from Hawaii as claimed by the authors, but from a country (or countries) in southeast Asia. Finally, we believe that the authors did not follow proper international guidelines, extend a professional courtesy to the supplier of the disputed shrimp sample, nor take a critical approach in interpreting their own data. It is unfortunate that the authors did not follow through with additional testing, or seek a second opinion from an independent laboratory, before implicating shrimp imported from Hawaii as the source of TSV in Korea.